_ WEEL OCCUPATIONAL ALLIANCE FOR RISK SCIENCE - WORKPLACE EVIRONMENTAL EXSPOSURE LEVELS OARS What we bring your company
and your workers
The Occupational Alliance for Risk Science-Workplace Environmental Exposure Levels (OARS-WEEL) stands as a crucial resource for fostering informed decision-making in occupational health and safety. Designed to bridge the gap between scientific knowledge and practical application, OARS-WEEL facilitates the dissemination of vital information to workers, companies, and occupational health and safety professionals.

At its core, the WEEL committee, operating under the OARS-WEEL umbrella, provides a dynamic forum for the exchange of exposure guidance concerning chemical stressors, alongside methodologies aimed at enhancing occupational risk assessments. Recognizing the diverse needs of its audience, OARS-WEEL also offers tailored training opportunities, ensuring that professionals are equipped with the latest knowledge and skills. Furthermore, the OARS-WEEL website acts as a centralized repository for exposure guide values and related guideline documents, all meticulously developed and published by the WEEL committee.

Collectively, these resources encompass worker and community exposure levels for a wide array of chemical and physical agents and stressors. Managed by Toxicology Excellence for Risk Assessment (TERA), OARS-WEEL is committed to advancing the field of occupational risk science and promoting safer workplaces
More

LATEST NEWS

• January 2025: OARS WEEL documentation for Methyltrimethoxysilane (MTMS) was published online in Toxicology and Industrial Health. Available at: https://journals.sagepub.com/doi/full/10.1177/07482337241301523 

• January 2025: OARS WEEL documentation for (E)-1,1,1,2,2,5,5,6,6,6-Decafluoro-3-hexene (HFO-153-10mczz-E) was published online in Toxicology and In• November 2024: OARS WEEL documentation for Vinyltrimethoxysilane (VTMS) as been submitted to Toxicology and Industrial Health for publication.

• November 2024: OARS WEEL documentation for Vinyltrimethoxysilane (VTMS) as been submitted to Toxicology and Industrial Health for publication.

• June 2024: OARS WEEL documentation for Bis-(2-Chloroisopropyl) Ether (BCIPE) was published online in Toxicology and Industrial Health. Available at: https://journals.sagepub.com/doi/10.1177/07482337241245745. For questions, please contact Chijioke Onyema at onyema@tera.org

• June 2024: OARS WEEL documentation for HFO-153-10mczz-E has been submitted to Toxicology and Industrial Health for publication.

• June 2024: OARS WEEL documentation for Methyltrimethoxysilane (MTMS) has been submitted to Toxicology and Industrial Health for publication.

Call US at 513.542.7475

Table of Chemicals

SubstanceCASSource8-Hour TWACeiling or Short-Term TWA
Acetone Cyanohydrin75-86-5AIHA2 ppm (skin)5 ppm (15 min, skin)
Acetophenone98-86-2AIHA10 ppm
Aldicarb116-06-3AIHA0.01 mg/m3 (skin)
Allyl lsothiocyanate57-06-7AIHA1 ppm (15-min, skin, DSEN)
Aminobenzoic Acid, para-150-13-0AIHA5 mg/m3
Aminotri (Methylenephosphonic Acid)6419-19-8AIHA10 mg/m3
Amyl Alcohol, n-71-41-0AIHA100 ppm
Benzaldehyde100-52-7AIHA2 ppm4 ppm (15-min, DSEN)
Benzenesulfonicacid, 5-chloro-2((2-Hydroxy-1 napthalenyl)-azo)-4-methyl, barium salt (2:1)2/1/5160AIHA1 mg/m3
Benzophenone119-61-9AIHA0.5 mg/m3
Benzoyl Chloride98-88-4AIHA5 ppm (ceiling, skin, DSEN)
Benzyl Alcohol100-51-6AIHA10 ppm
Butylcatechol, 4-tert-98-29-3AIHA2 mg/m3 (ceiling, skin, DSEN)
Butyraldehyde123-72-8OARS25 ppm (75 mg/m3)
Chloramphenicol56-75-7AIHA0.5 mg/m3
ChIoroisopropyI)Ether, bis-(2-39638-92-9AIHA3 ppm
Chloropropane, 2-75-29-6OARS50 ppm (161 mg/m3)
Chlorosulfonic Acid7790-94-5OARS
Chlorotrifluoroethylene79-38-9AIHA5 ppm
Cumene Hydroperoxide80-15-9AIHA1 ppm (skin)
Decabromodiphenyl Oxide1163-19-5AIHA5 mg/m3
Decafluoropentane, 1,1,1,2,3,4,4,5,5,5- (HFC- 4310mee)138495-42-8OARS225 ppm (2320 mg/m3)700 ppm (7217mg/m3)
Decafluoro-3-hexene, (E)- 1,1,1,2,2,5,5,6,6,6- (HFO-153-10mczz-E)1256353-26-0OARS200 ppm (2160 mg/m3)
Decamethylcyclopentasiloxane (D5)541-02-6OARS10 ppm
Decene, 1-872-05-9AIHA100 ppm
Dehydrolinalool29171-20-8AIHA2 ppm
Diallylamine124-02-7AIHA1 ppm (skin)
Dibromoneopentyl Glycol3296-90-0AIHA0.2 mg/m3
Dibutylamine111-92-2AIHA5 ppm (ceiling, skin)
Dichlorophenol, 2,4-120-83-2AIHA1 ppm (skin*)
Diethylbenzenes, mixed isomers25340-17-4AIHA5 ppm
Diethylene Glycol111-46-6OARS10 mg/m3
Diethylene Glycol Monoethyl Ether111-90-0AIHA25 ppm
Difluoroethane, 1,1-75-37-6AIHA1000 ppm
Difluoroethane, 1-ChIoro-1,1-75-68-3AIHA1000 ppm
Difluoroethylene, (E)-1,2 (HFO-1132 (E)1630-78-0OARS350 ppm
Difluoromethane75-10-5AIHA1000 ppm
Diisobutylene25167-70-8OARS75 ppm (344 mg/m3 )
Dimethyl Ether (DME)115-10-6AIHA1000 ppm
Dimethyl Sulfoxide67-68-5AIHA250 ppm
Dimethyl Terephthalate120-61-6AIHA5 mg/m3 (total)
Dimethyldichlorosilane75-78-5AIHA2 ppm (ceiling)
Dimethylethylamine598-56-1AIHA1 ppm3 ppm
Dimethyl-para-toluidine, n,n-99-97-8AIHA0.5 ppm
Dinitroanisole, 2,4- (DNAN)119-27-7OARS0.1 mg/m3 (0.01 ppm)
Dowtherm Q612-00-0,68987-42-8AIHA7.8 mg/m3
Epoxybutane, 1,2-106-88-7AIHA2 ppm
Erythromycin114-07-8AIHA3 mg/m3
Fluoroethane, 1,1-dichloro-1-1717-00-6AIHA500 ppm3000 ppm (5-min STEL)
Furan110-00-9AIHAWorker exposure by all routes should be minimalized to the fullest extent possible.
Glycidyl Methacrylate106-91-2AIHA0.5 ppm (skin, DSEN)
Glyoxal107-22-2AIHA0.1 mg/m3 (DSEN)
Hexadiene, 1,4- (mixed cis and trans)592-45-0AIHA10 ppm
Hexafluoro-2-butene, cis-1,1,1,4,4,4- (HFO 1336mzz-Z)692-49-9OARS500 ppm (3350 mg/m3)
Hexafluoro-2-butene, trans-1,1,1,4,4,4- (HFO 1336mzz-E)66711-86-2OARS400 ppm (2680 mg/m3)
Hexafluoropropane, 1,1,1,3,3,3-690-39-1AIHA1000 ppm
Hexamethyldisilazane (HMDZ)999-97-3OARS10 ppm50 ppm
Hexamethylene Glycol629-11-8AIHA10 mg/m3
Hexanediamine, 1,6-124-09-4AIHA1 ppm
Hexanediol Diacrylate13048-33-4AIHA1 mg/m3 (DSEN)
Hexyl Alcohol, n-111-27-3AIHA40 ppm (eye irritation)
HFE-7100163702-07-6, 163702-08-7AIHA750 ppm
Hydroxybenzoic Acid, 4-99-96-7OARS5 mg/m3
Isobutyraldehyde78-84-2AIHA25 ppm
Isocyanuric Acid108-80-5AIHA10 mg/m3 (total); 5 mg/m3 (respirable)
Isophthalic Acid121-91-5AIHA10 mg/m3 (total); 5 mg/m3 (respirable)
Isoprene78-79-5AIHA2 ppm
Limonene, d-5989-27-5AIHA30 ppm
Lithium Hydroxide1310-65-2AIHA1 mg/m3 (ceiling)
Lithium Oxide12057-24-8AIHA1 mg/m3 (ceiling)
Mancozeb1/7/8018AIHA1 mg/m3 (total, DSEN)
Melamine108-78-1OARS3 mg/m3
Menthol1490-04-6OARS1 ppm3 ppm (15 min)
Mercaptobenzothiazole, 2-149-30-4AIHA5 mg/m3 (skin, DSEN)
Mercaptoethanol60-24-2AIHA0.2 ppm (skin)
Methoxypropylamine, 3-5332-73-0AIHA5 ppm15 ppm (15 min)
Methoxytridecafluoroheptene isomers (MPHE)VariableOARS200 ppm
Methyl Ethyl Ketoxime96-29-7AIHA10 ppm (DSEN)
Methyl-2-PyrroIidone, n- (NMP)872-50-4OARS15 ppm (60 mg/m3) Skin30 ppm (120 mg/m3)
Methyltrichlorosilane75-79-6AIHA1 ppm (ceiling)
Methyltrimethoxysilane (MTMS)1185-55-3OARS 10 ppm
Monochloroacetic Acid79-11-8AIHA0.5 ppm (skin)
Nitro-1,2,4-TriazoI-5-One, 3- (NTO)932-64-9OARS2 mg/m3
Nitroguanidine, 1- (NQ)556-88-7OARS7 mg/m3
Octamethylcyclotetrasiloxane (D4)556-67-2OARS10 ppm
Octanol, 1-111-87-5AIHA50 ppm
Octene, 1-111-66-0AIHA75 ppm
Pentaerythritol Triacrylate3524-68-3AIHA1 mg/m3 (DSEN)
Pentafluoroethane, 1,1,1,2,2-354-33-6AIHA1000 ppm
Pentafluoropropane, 1,1,1,3,3-460-73-1AIHA300 ppm
Phosphono-1,2,4 butanetricarboxylic, 2-acid37971-36-1AIHA10 mg/m3
Picolines109-06-8, 108-99-6, 108-89-4AIHA2 ppm (skin)5 ppm (15-min, skin)
Piperidine110-89-4AIHA1 ppm (skin)
Polyethylene Glycols (MW > 200)25322-68-3AIHA10 mg/m3
Polypropylene Glycols25322-69-4AIHA10 mg/m3
Potassium Bromate1/2/7758AIHA0.1 mg/m3
Propargyl Bromide106-96-7AIHA0.1 ppm (skin)
Propenoic Acid, isooctyl ester, 2-29590-42-9AIHA5 ppm
Propionaldehyde123-38-6AIHA20 ppm
Propylene Glycol57-55-6AIHA10 mg/m3
Propylene Glycol Monomethyl Ether Acetate108-65-6AIHA50 ppm
Quinoline91-22-5AIHA0.001 ppm (skin)
Sodium Chloroacetate3926-62-3OARS0.5 ppm (2.5 mg/m3 )
Sodium Hypochlorite7681-52-9AIHA2 mg/m3 (15 min)
Tetrachloropyridine, 2,3,5,6-2402-79-1OARS5 mg/m3
Tetrachlorosilane10026-04-7AIHA1 ppm (ceiling)
Tetraethylene Glycol Diacrylate17831-71-9AIHA1 mg/m3 (skin, DSEN)
TetraethylenePentamine112-57-2AIHA5 mg/m3 (skin, DSEN)
Tetrafluoroethane, 1,1,1,2- (HFC-134a)811-97-2AIHA1000 ppm
Tetrafluoroethane, 1,1,2,2- (HFC-134)359-35-3OARS1000 ppm
Tetrafluoroethane, 2-ChIoro-1,1,1,2-2837-89-0AIHA1000 ppm
Tetrafluoropropene, (Z)-1-ChIoro-2,3,3,3- (HCFO-1224yd(Z))111512-60-8OARS1000 ppm
Tetrafluoropropene, 2,3,3,3,- (HFO-1234yf)754-12-1AIHA500 ppm
Tetrafluoropropylene, 1,3,3,3-1645-83-6AIHA800 ppm
Tetrahydrofurfuryl Alcohol97-99-4AIHA0.5 ppm (skin)
Titanium Tetrachloride7550-45-0AIHA0.5 mg/m3
Toluene Diamine, 2,4- and mixed isomers95-80-7; 25376-45-8AIHA0.005 ppm (skin)
Toluenesulfonyl Chloride, para-98-59-9AIHA5 mg/m3 (ceiling)
trans-1-Chloro-3,3,3-trifluoropropylene (HCFO 1233zd(E))102687-65-0OARS800 ppm
Trichlorosilane10025-78-2AIHA0.5 ppm (ceiling)
Triethoxysilane998-30-1AIHA0.05 ppm
Triethylene Glycol Diacrylate1680-21-3AIHA1 mg/m3 (skin)
Triethylenetetramine (TETA)112-24-3AIHA1 ppm (skin)
Triethylphosphate78-40-0AIHA7.45 mg/m3
TrifIuoro-2,2-Dichloroethane, 1,1,1-306-83-2AIHA50 ppm
Trifluoroethane, 1,1,1-420-46-2AIHA1000 ppm
Trifluoroethanol, 2,2,2-75-89-8OARS0.3 ppm
Trifluoroiodomethane (CF3I)2314-97-8OARS500 ppm1500 ppm
Trimethoxysilane2487-90-3AIHA0.05 ppm
Trimethylamine75-50-3AIHA1 ppm
Trimethylchlorosilane75-77-4AIHA5 ppm (ceiling)
Trimethylolpropane Triacrylate15625-89-5AIHA1 mg/m3 (skin)
Trimethylolpropane Trimethacrylate3290-92-4AIHA1 mg/m3 (skin)
Trisodium Phosphate7601-54-9AIHA5 mg/m3 (15 min)
Urea57-13-6AIHA10 mg/m3
Vanillin121-33-5AIHA10 mg/m3
Vinylcyclohexene100-40-3AIHA1 ppm
Vinyltrichlorosilane75-94-5AIHA1 ppm (ceiling)

*Value withdrawn

Substances Considered But Determined to Have an Inadequate Minimum Data Set:

Chlorine Monoxide Methylene Butanedioic Acid 1,3-Pentadiene

Our Brands

  • ITER ITER

Contacts

  • 1250 Ohio Pike, Suite 197, Cincinnati Ohio 45102
  • 513.488.1990
  • TERA@TERA.ORG

You will be redirected to a secure payment portal

The WEEL Committee

The OARS-WEEL Committee is composed of volunteer experts specializing in the scientific determination of occupational exposure levels. This committee actively seeks a balanced representation of professionals from toxicology and industrial hygiene, drawing upon a diverse range of experience from industry, government, academia, and consulting. Importantly, each member contributes to the Committee based on their individual expertise and not as an official representative of their respective employer, organization, or agency.

The WEEL Process
Click Here

The development of new or revision of existing WEELs is typically assigned to voluntarily designated subcommittees. A subcommittee usually comprises 3 – 4 members from the WEEL Committee. New WEELs are developed using the OARS-WEEL administrative standard operating procedure (SOP), while existing WEELs are usually revised every 10 years, unless the availability of significant new data which may impact the existing WEEL value compels the committee to make a revision sooner. The OARS-WEEL SOP contains procedures and guidelines governing conflicts of interest, draft document preparation, literature searches, draft document review, balloting process, post-ballot WEEL documentation quality assurance scientific review, and publication.

Once a subcommittee has prepared a draft WEEL document, a review of the draft is scheduled for the next available Committee meeting. The WEEL Committee members are expected to have reviewed all such drafts prior to the meeting. If no major changes are necessary to a draft, the attending Committee membership may, by a simple majority, approve the WEEL for balloting. Alternatively, the Committee may direct the subcommittee to revise the WEEL and present it for further discussion at a future meeting. If a ballot is not approved by a two-thirds majority of non-abstaining Committee members, it is discussed at the next Committee meeting to determine the appropriate course of action. Once the WEEL is approved by a two-thirds majority of non-abstaining Committee members, copies of ballot comments are forwarded to the designated subcommittee and all substantive comments must be addressed in the final draft. If resolution of a substantive comment results in a change to the WEEL value or a change in the basis for the value, the draft must be re-balloted.

Once all comments have been addressed on a successfully balloted draft, document formatting and editorial review are performed by TERA, before the draft WEEL document is made available for public comment (usually for a period of 30 days but may be extended if the need arises). After the public comment period has elapsed, comments are addressed by the subcommittee responsible for that specific draft, after which the WEEL documentation is submitted to Toxicology and Industrial Health (TIH), a peer-reviewed medical journal that covers research in the fields of occupational health and toxicology, for publication. A thorough review of the galley proof by the scientific content quality coordinator at TERA, and proofreaders and editors at TIH is the penultimate step before eventual publication of the WEEL documentation.

WEEL OEL

Occupational Exposure Limits (OELs) are designed to safeguard the health of healthy workers during their careers. These limits are based on the assumption of repeated daily exposure throughout a working lifetime, typically averaged over an 8-hour workday. Their purpose is to prevent both immediate (acute) and long-term (chronic) health issues arising from workplace exposures. It’s important to note that OELs are not intended for the general public, which includes vulnerable groups like infants, the elderly, and those with pre-existing health conditions.

Workplace Environmental Exposure Levels (WEELs) are health-based guidelines for chemical hazards in the workplace. These values represent air concentrations believed to protect the majority of workers from negative health effects resulting from occupational chemical exposure.